Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-30
2005-08-30
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S083000
Reexamination Certificate
active
06936623
ABSTRACT:
Compounds of the formula (I), in which the substituents have the meanings mentioned in the description, are suitable for the prevention and treatment of gastrointestinal diseases.
REFERENCES:
patent: 6160119 (2000-12-01), Senn-Bilfinger
patent: WO 95/27714 (1995-10-01), None
patent: WO 98/54188 (1998-03-01), None
patent: WO 98/42707 (1998-10-01), None
Bundgaard, H. Design of Prodrugs. (1985) Elsevier. Amsterdam-New York-Oxford. pp. 1-3.
Buhr Wilm
Senn-Bilfinger Jörg
Altana Pharma AG
Aulakh Charanjit S.
Goldberg Joshua B.
McGee Sheldon M.
Nath & Associates PLLC
LandOfFree
Pyrano[2,3-C]imidazo[-1,2-A]pyridine derivatives for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrano[2,3-C]imidazo[-1,2-A]pyridine derivatives for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrano[2,3-C]imidazo[-1,2-A]pyridine derivatives for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3444575